The Allstate Co. (NYSE:ALL) Shares Sold by Leeward Investments LLC MA

Leeward Investments LLC MA reduced its position in The Allstate Co. (NYSE:ALL) by 20.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 117,393 shares of the insurance provider’s stock after selling 29,849 shares during the period. Allstate makes up approximately 1.0% of Leeward Investments LLC MA’s holdings, making the stock its 26th largest holding. Leeward Investments LLC MA’s holdings in Allstate were worth $22,179,000 at the end of the most recent quarter.

A number of other institutional investors have also modified their holdings of the company. Spinnaker Trust purchased a new stake in Allstate during the third quarter worth approximately $229,000. Radnor Capital Management LLC purchased a new stake in Allstate during the 3rd quarter worth $302,000. Leslie Global Wealth LLC acquired a new stake in Allstate in the 3rd quarter valued at $210,000. Catalina Capital Group LLC purchased a new position in Allstate in the third quarter valued at about $253,000. Finally, Avidian Wealth Enterprises LLC lifted its stake in shares of Allstate by 4.7% during the third quarter. Avidian Wealth Enterprises LLC now owns 5,473 shares of the insurance provider’s stock worth $1,038,000 after purchasing an additional 247 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Analyst Upgrades and Downgrades

ALL has been the topic of several analyst reports. Morgan Stanley raised their target price on Allstate from $202.00 to $215.00 and gave the company an “overweight” rating in a report on Monday, October 21st. StockNews.com lowered shares of Allstate from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, August 21st. Piper Sandler upped their target price on shares of Allstate from $188.00 to $196.00 and gave the company an “overweight” rating in a research note on Friday, August 16th. BMO Capital Markets lifted their price target on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Finally, Raymond James upped their price objective on shares of Allstate from $205.00 to $220.00 and gave the company a “strong-buy” rating in a research report on Friday, October 4th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $209.50.

Allstate Stock Up 2.0 %

Shares of NYSE:ALL opened at $188.69 on Thursday. The Allstate Co. has a 1-year low of $127.93 and a 1-year high of $198.79. The company’s fifty day moving average is $188.89 and its two-hundred day moving average is $175.59. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The stock has a market capitalization of $49.97 billion, a price-to-earnings ratio of 12.22, a price-to-earnings-growth ratio of 1.73 and a beta of 0.48.

Allstate (NYSE:ALL) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.20 by $1.71. The firm had revenue of $16.63 billion for the quarter, compared to analysts’ expectations of $14.57 billion. Allstate had a net margin of 6.77% and a return on equity of 26.67%. Allstate’s revenue was up 14.7% on a year-over-year basis. During the same quarter last year, the company posted $0.81 earnings per share. Equities analysts anticipate that The Allstate Co. will post 15.23 EPS for the current year.

Insider Activity at Allstate

In other news, insider John E. Dugenske sold 36,367 shares of the company’s stock in a transaction dated Friday, September 20th. The shares were sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now owns 27,364 shares in the company, valued at approximately $5,236,922.32. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider John E. Dugenske sold 36,367 shares of the business’s stock in a transaction that occurred on Friday, September 20th. The stock was sold at an average price of $191.38, for a total transaction of $6,959,916.46. Following the completion of the transaction, the insider now directly owns 27,364 shares in the company, valued at approximately $5,236,922.32. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Thomas J. Wilson sold 90,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $179.34, for a total value of $16,140,600.00. Following the completion of the sale, the chief executive officer now owns 88,552 shares in the company, valued at approximately $15,880,915.68. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 192,530 shares of company stock worth $34,967,665 in the last 90 days. 1.80% of the stock is currently owned by company insiders.

About Allstate

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.